American Century Companies Inc. acquired a new position in shares of Avantor, Inc. (NYSE:AVTR – Free Report) during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund acquired 1,524,991 shares of the company’s stock, valued at approximately $19,032,000. American Century Companies Inc. owned about 0.22% of Avantor as of its most recent SEC filing.
A number of other institutional investors also recently made changes to their positions in AVTR. Argent Trust Co acquired a new stake in shares of Avantor during the third quarter worth approximately $462,000. Quantbot Technologies LP grew its holdings in Avantor by 1,333.0% during the 3rd quarter. Quantbot Technologies LP now owns 246,494 shares of the company’s stock worth $3,076,000 after acquiring an additional 229,293 shares in the last quarter. Rock Creek Group LP acquired a new position in Avantor during the 3rd quarter worth $1,248,000. Handelsbanken Fonder AB increased its position in shares of Avantor by 19.7% in the 3rd quarter. Handelsbanken Fonder AB now owns 197,300 shares of the company’s stock worth $2,462,000 after purchasing an additional 32,500 shares during the last quarter. Finally, Diversify Wealth Management LLC increased its position in shares of Avantor by 6.4% in the 3rd quarter. Diversify Wealth Management LLC now owns 61,559 shares of the company’s stock worth $719,000 after purchasing an additional 3,685 shares during the last quarter. 95.08% of the stock is owned by institutional investors and hedge funds.
Avantor Trading Up 0.1%
Shares of NYSE AVTR opened at $8.16 on Wednesday. Avantor, Inc. has a 12-month low of $7.82 and a 12-month high of $17.29. The company has a market cap of $5.56 billion, a price-to-earnings ratio of -10.46, a price-to-earnings-growth ratio of 3.20 and a beta of 0.97. The company has a current ratio of 1.78, a quick ratio of 1.18 and a debt-to-equity ratio of 0.70. The stock’s 50 day simple moving average is $10.57 and its 200 day simple moving average is $11.77.
Insider Activity
In other Avantor news, Director Gregory L. Summe acquired 100,000 shares of Avantor stock in a transaction dated Thursday, February 12th. The stock was acquired at an average cost of $9.40 per share, for a total transaction of $940,000.00. Following the completion of the transaction, the director owned 400,000 shares in the company, valued at approximately $3,760,000. This represents a 33.33% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Gregory T. Lucier acquired 50,000 shares of the firm’s stock in a transaction that occurred on Thursday, February 19th. The stock was acquired at an average cost of $9.16 per share, with a total value of $458,000.00. Following the completion of the acquisition, the director directly owned 50,000 shares in the company, valued at approximately $458,000. This represents a ∞ increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Company insiders own 1.20% of the company’s stock.
Wall Street Analysts Forecast Growth
AVTR has been the topic of several research analyst reports. Stifel Nicolaus set a $10.00 price target on shares of Avantor in a research report on Thursday, February 12th. Citigroup lowered their price objective on Avantor from $13.00 to $11.00 and set a “neutral” rating for the company in a report on Thursday, February 12th. Jefferies Financial Group restated an “underperform” rating and set a $8.00 price objective on shares of Avantor in a research note on Thursday, February 12th. Zacks Research downgraded Avantor from a “hold” rating to a “strong sell” rating in a report on Friday, February 13th. Finally, Robert W. Baird set a $11.00 target price on Avantor in a research report on Thursday, February 12th. Three equities research analysts have rated the stock with a Buy rating, ten have given a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $11.80.
Read Our Latest Stock Analysis on AVTR
About Avantor
Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.
Avantor’s offerings are organized across two primary segments.
Further Reading
- Five stocks we like better than Avantor
- The gold chart Wall Street is terrified of…
- What a Former CIA Agent Knows About the Coming Collapse
- Elon Musk already made me a “wealthy man”
- Unlocked: Elon Musk’s Next Big IPO
- 1,500 Banks Just Handed the Fed Your Bank Account
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.
